| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Clover Health Investments, Corp. (CLOV) has 14 insiders with recent SEC Form 4 filings, including 2 buys and 9 sells. CLOV is classified in the Health Care Providers & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 9.57M | $49.19M | - | |
| CFO | 5.92M | $30.40M | - | |
| CEO | 2.84M | $14.60M | -2,360 | |
| CEO | 2.25M | $11.58M | - | |
| ? | 1.86M | $9.54M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 2,360 | $4.78 | $11,280.80 | - | - | - | |
| Jun 16, 2026 | Oldakowski Joseph Frank | VP Of Finance And Controller | Sell | 12,102 | $4.86 | $58,815.72 | -3.9% | - | - | |
| May 28, 2026 | Wai Conrad | CEO, Counterpart Health | Sell | 220,426 | $3.99 | $879,499.74 | -13.7% | - | - | |
| Jan 7, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 2,102 | $2.53 | $5,318.06 | - | -24.0% | - | |
| Dec 18, 2025 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 4,913 | $2.61 | $12,822.93 | -0.2% | -27.1% | - | |
| Nov 4, 2025 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 30,385 | $3.58 | $108,778.30 | -1.1% | -37.5% | - | |
| Oct 17, 2025 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 16,514 | $2.69 | $44,422.66 | -0.6% | -3.3% | - | |
| Oct 7, 2025 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 2,012 | $2.65 | $5,331.80 | - | -4.1% | - | |
| Sep 17, 2025 | Reynoso Jamie L. | CEO, Medicare Advantage | Sell | 4,914 | $3.09 | $15,184.26 | -0.2% | -14.0% | - | |
| Aug 13, 2025 | Loengard Anna U82 | Director | Buy | 26,500 | $2.59 | $68,755.00 | +86.3% | -2.7% | - |